Status:

UNKNOWN

Comparing Virtual Reality Therapy With Modified-CIMT Versus Modified-CIMT Alone in Hemiparetic Children

Lead Sponsor:

All India Institute of Medical Sciences

Conditions:

Hemiparesis

Eligibility:

All Genders

5-18 years

Phase:

NA

Brief Summary

This study intends to compare the efficacy of of virtual reality therapy(VRT) with modified constraint induced movement therapy(mCIMT) versus modified constraint induced movement therapy alone for chi...

Detailed Description

Sample size: Based on the previous studies, on CIMT in hemiparetic CP children using QUEST scores, * Anticipated increase in total QUEST scores at 2 months in the mCIMT group: 10 + 5(mean + SD) * ...

Eligibility Criteria

Inclusion

  • Children aged \>5-18 years
  • Children with hemiparetic cerebral palsy \* (both perinatal and postnatal acquired brain injury)
  • Intelligence quotient \>70 (Binet Kamat Test/Malin's Intelligence Scale for Children)
  • Modified Ashworth scoring 1-3 for affected limb
  • Can sit independently or with support (Gross Motor Functional Classification System stage: 1-4 and Manual Ability Classification System stage: 1-3)
  • Preserved vision and hearing (with or without correction)

Exclusion

  • Uncontrolled epilepsy as defined by seizure frequency \>1/month for preceding 3 months
  • Severe concurrent illness or diseases not associated with CP or unstable medical conditions like pneumonia
  • Genetic or syndromic associations
  • Children diagnosed with autistic spectrum disorders
  • Modified Ashworth scale score more than 3 at shoulder/elbow /wrist
  • Contractures of the affected limb
  • Severe movement disorder like dystonia, choreo-athetosis or ballismus interfering with purposeful limb movement
  • Any congenital brain malformation detected on conventional MRI brain
  • Recent orthopedic surgery/cast/splint in the affected limb
  • Botulinum toxin/phenol blocking in the affected limb in the past 6 months or are planning to receive in the study period
  • Those receiving tone modifying agents in week before enrollment(Tizanidine,baclofen,benzodiazepines,dantrolene)
  • Any contraindications for MRI - examples- presence of pacemaker, metallic implant

Key Trial Info

Start Date :

September 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03237520

Start Date

September 1 2017

End Date

August 1 2018

Last Update

August 10 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.